Volume : 08, Issue : 08, August – 2021

Title:

31.REVASCULARIZATION STRATEGIES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION AND MULTI-VESSEL CORONARY ARTERY DISEASE, MULTI-VESSEL STAGED PCI VERSUS CULPRIT VESSEL ONLY PCI: A SYSTEMATIC REVIEW

Authors :

Muhammad Hammad Sharif, Muhammad Irfan, Adnan Khan, Madeeha Khaleeque, Faridoon Masood

Abstract :

Percutaneous coronary intervention (PCI) is the standard modality for treatment of ST-elevation myocardial infarction (STEMI) that results in improved outcomes as compared to medical therapy alone. The favorable revascularization strategy has been a debate as some centers prefer culprit vessel only PCI while others favoring staged multi-vessel PCI. Although the older guidelines might favor a culprit vessel only PCI technique but the current evidence now points in favor of staged multi-vessel PCI in patients with multi-vessel coronary artery disease. The vast data of randomized clinical trials conducted on patients with multi-vessel coronary artery disease have shown favorable outcomes in terms of all-cause mortality, repeat revascularization, myocardial infarction and composite of death, MI and stroke as compared to the patients who underwent culprit vessel only PCI at hospitalization. The purpose of our study is to shed light on the preferred revascularization strategy in patients with multi-vessel coronary artery disease. We conducted a thorough search of clinical trials and meta-analysis on the topic of favorable revascularization strategy in patients with multi-vessel coronary artery disease and it showed the superiority of staged multi-vessel PCI over culprit vessel only PCI.
Keywords: Staged multi-vessel PCI, Culprit vessel only PCI, Percutaneous Coronary Intervention, ST-Elevation Myocardial Infarction, Revascularization.

Cite This Article:

Please cite this article in press Muhammad Hammad Sharif et al., Revascularization Strategies In Patients With St-Elevation Myocardial Infarction And Multi-Vessel Coronary Artery Disease, Multi-Vessel Staged PCI Versus Culprit Vessel Only PCI: A Systematic Review., Indo Am. J. P. Sci, 2021; 08(08).

Number of Downloads : 10

References:

1- Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J. 1991;121(4 Pt 1):1042-1049. doi:10.1016/0002-8703(91)90661-z
2- Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-2619. doi:10.1093/eurheartj/ehs215
3- O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82(1):E1-E27. doi:10.1002/ccd.24776
4- Khattab AA, Abdel-Wahab M, Röther C, et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol. 2008;97(1):32-38. doi:10.1007/s00392-007-0570-4
5- Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010;3(1):22-31. doi:10.1016/j.jcin.2009.10.017
6- Toyota T, Shiomi H, Taniguchi T, et al. Culprit Vessel-Only vs. Staged Multivessel Percutaneous Coronary Intervention Strategies in Patients With Multivessel Coronary Artery Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Circ J. 2016;80(2):371-378. doi:10.1253/circj.CJ-15-0493
7- Wood DA, Cairns JA, Wang J, et al. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. J Am Coll Cardiol. 2019;74(22):2713-2723. doi:10.1016/j.jacc.2019.09.051
8- Sadjadieh G, Engstrøm T, Helqvist S, et al. Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy. EuroIntervention. 2016;12(10):1231-1238. doi:10.4244/EIJV12I10A203
9- Cui K, Lyu S, Liu H, et al. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes. Cardiovasc Diabetol. 2019;18(1):119. Published 2019 Sep 17. doi:10.1186/s12933-019-0923-0
10- Atti V, Gwon Y, Narayanan MA, et al. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv. 2020;13(13):1571-1582. doi:10.1016/j.jcin.2020.04.055
11- Tarantini G, D’Amico G, Brener SJ, et al. Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis. JACC Cardiovasc Interv. 2016;9(17):1765-1776. doi:10.1016/j.jcin.2016.06.012